Italian Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals

Results

0 new

High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.

2 companies

Philogen

Market Cap: €935.7m

A biotechnology company, develops drugs for oncology and chronic inflammatory diseases in Switzerland and the European Union.

PHIL

€23.20

0.9%

16.0%

Fine Foods & Pharmaceuticals N.T.M

Market Cap: €217.6m

Fine Foods & Pharmaceuticals N.T.M. S.p.A.

€8.90

3.0%

10.4%